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Background. Naegleria Fowleri is a single-cell, thermophilic amphizoid amoeba, and a rare known causative agent for primary
amoebic meningoencephalitis with >97% mortality rate. The amoeba resides in freshwater lakes and ponds but can also survive
in inadequately chlorinated pools and recreational waters. The mode of infection includes activities such as diving or jumping
into freshwater or submerging the head under the water. Although most commonly seen in the southern United States, it is
essential to keep this clinical suspicion in mind regardless of geography, as presenting symptoms can be very similar to classic
bacterial meningitis. Case Summary. We report the ﬁrst-ever case in the state of New Jersey of a 29-year-old male presented
after a visit to a recreational water park in Texas ﬁve days before his presentation with altered mental status. In ICU, his ICP
remained refractory to multiple therapies, including antibiotics and antivirals, external ventriculostomy drain, hypertonic saline,
pentobarbital-induced coma, and bilateral hemicraniectomies. The CSF analysis revealed trophozoites indicating a protozoan
infection, which we diagnosed in the neurocritical unit, and the patient was then immediately started with treatment that
included amphotericin B, rifampin, azithromycin, and ﬂuconazole. This suspicion was promptly conﬁrmed by the Center for
Disease Control (CDC). Unfortunately, despite all the aggressive intervention by the multidisciplinary team, the patient did not
survive. Conclusion. As per the CDC, only four people out of 143 known infected individuals in the United States from 1962 to
2017 have survived. Symptoms start with a median of 5 days after exposure to contaminated water. Given the rarity of this case
and its very high mortality rate, it is crucial to diagnose primary amoebic meningoencephalitis accurately as its presentation can
mimic bacterial meningitis. It is vital to obtain a careful and thorough history, as it can aid in prompt diagnosis and treatment.

1. Introduction
The genus Naegleria is composed of over 30 diﬀerent species
made of a group of free-living ameboﬂagellate found in
diverse habitat [1]. But only Naegleria fowleri has been isolated from the humans and a known agent for primary amoebic encephalitis. N. fowleri is a thermophilic amphizoid
amoeba, single-celled microbe, commonly found around
the world in warm freshwater [1]. Environmental conditions,
including desiccation, salinity, and chlorination, aﬀect their

survival [2]. It can exist in a free-living state in water or soil
or as a pathogen in human hosts, hence the term amphizoid.
Naegleria spp. have been isolated from freshwater lakes,
ponds, domestic water supplies, swimming pools, thermal
pools, soil, and dust. Human disease caused by N. fowleri
was ﬁrst reported by Fowler and Carter in South Australia
[3]. Although most commonly seen in southern states in
the United States, it is essential to keep this clinical suspicion
in mind regardless of geography, as presenting symptoms
can be very similar to classic bacterial meningitis. Symptoms
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Figure 1: This illustration depicts the life cycle of Naegleria fowleri, the parasitic agents responsible for causing free-living amebic infections.
Content Providers are CDC/ Alexander J. da Silva, PhD, and Melanie Moser. N. Fowleri has 3 stages in its life cycle: (1) cyst, (2) trophozoite,
and ﬂagellate (3). The only infective stage is the trophozoite which is 10-35 μm long with a granular appearance and a single nucleus. They
replicate by binary division during which the nuclear membrane remains intact (promitosis) (4). Trophozoites infect humans or animals by
penetrating the nasal tissue (5).

include fever, headaches, nausea along with nuchal rigidity,
and sometimes seizures. As per the CDC, an infection can
occur by recreational water activities, but not by drinking
contaminated water with Naegleria. However, there have
been reports of disease via nasal lavage. The majority of infections in the United States are prevalent in southern states
arising in summer months, where the organism is found in
geothermal water such as hot springs, lakes, poorly maintained swimming pools, and recreational waters. N. fowleri
has the best growth at higher temperatures up to 115°F
(46°C). The three morphological stages in the life cycle
include a trophozoite, ﬂagellate, and a cyst [4] (Figure 1).
The trophozoite is the feeding and dividing stage for humans;
however, the cyst can also enter through the nares and con-

vert to trophozoites [4]. They attach to the nasal mucosa
and then migrate through olfactory nerves across the cribriform plate and penetrate the brain tissue.
Through cytotoxic eﬀects, the organism starts tissue
destruction of nerve cells and ingestion of erythrocytes initiating an inﬂammatory response that consists of neutrophils,
eosinophils, and macrophages. The pathologic mechanism
includes proteinosis and possible lysis that contributes to
neuronal demyelination, and destruction and lysis of erythrocytes and surrounding nerve cells [5]. As a result, neuroimaging in PAM usually shows a single focus on infection in the
frontal lobe along with diﬀuse cerebral edema and basilar
meningeal enhancement [6]. The detection method includes
direct visualization under a microscope of fresh CSF samples
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Figure 2: CAT scan on admission showing (a) axial, (b) sagittal, (c) post hemicraniectomy within 12 hrs. of admission. Note, there is diﬀuse
sulcal eﬀacement in (a), possibly reﬂecting hypoxic-ischemic encephalopathy Vs meningitis.

using Giemsa Wright or modiﬁed trichrome stain, antigen
detection, PCR, or amoeba culture [7, 8]. As per the CDC,
in the last ten years, out of 34 cases reported in the United
States, 30 people were infected by recreational waters, and
half of the examples in the U.S have occurred in Texas and
Florida. Symptoms start with a median of 5 days after exposure to contaminated water. Due to the rarity of the infection
and its close presentation to bacterial meningitis, 75% of
diagnosis is made after the death of the patients [9].

2. Case Report
A 29-year-old Caucasian male with a past medical history of
Epstein-Barr virus infection in childhood presented to AtlantiCare Regional Medical Center in New Jersey, Atlantic City
division, with a sudden altered level of consciousness and
fevers up to 103°F. Upon initial assessment, the patient was
somnolent, altered, and not able to follow any commands.
The mother provided the history given the clinical condition
of the patient. She stated that the patient just returned ﬁve
days ago from Texas, where he went on vacation. Also pertinent was that he worked outdoors for the New Jersey Department of Environmental Protection in water testing facility.
Five days before his presentation, the patient was exposed
to recreational waters at a surﬁng park in Waco, Texas. On
physical examination, the patient was febrile and comatose
with a Glasgow Coma Scale of 7. His blood pressure was
153/75 mmHg with a pulse rate of 77 beats per minute and
an oral temperature of 103°F. Upon examination of lungs,
abdomen, and extremities, no abnormality was noted. No
features of chronic illnesses or palpable lymph nodes were
appreciated. On his neurologic exam, he was altered, moving
all extremities with a positive Brudzinski sign. We sedated
and intubated the patient for airway protection in the emergency department and admitted him to the neurocritical care
unit. A computerized tomography (CT) scan of the brain
showed no evidence of acute intracranial infarction or
hemorrhage; however, there was sulcal eﬀacement concerning for hypoxic/ischemic encephalopathy versus meningitis
(Figure 2). Given the patient’s presentation, the suspicion
was high for bacterial meningitis versus viral encephalitis.

Blood cultures, serologies for West Nile virus, Rocky Mountain spotted fever, cytomegalovirus, Herpes simplex virus,
Lyme’s disease, and an acute Epstein-Barr virus panel were
all obtained. The patient received 10 milligrams of IV dexamethasone. Vancomycin and meropenem plus acyclovir
were initiated for broad-spectrum coverage. In the intensive
care unit, a lumbar puncture demonstrated an opening pressure of 46 mmHg, and the procedure was aborted. We placed
a right frontal external ventricular drain (EVD) that revealed
an opening pressure of 15 mmHg. During this time, we collected the CSF and sent it for further studies. Cerebrospinal
ﬂuid studies showed a white cell count of 1021 cells/uL, red
blood cell count of 1830 cells/uL, the glucose of 98 mg/dL,
and a protein of 174 mg/dL. His peripheral white blood cell
count was 11400 cells/uL (83% segmented neutrophils).
The EVD was left open to drain at a pop oﬀ setting of
0 mmHg. An MRI of the brain done post admission showed
no evidence of acute infarction, and the ventricular volume
was normal.
On day one post admission, the patient’s ICP continued
to remain elevated, sustaining at 30-40 mmHg despite EVD
placement and multiple interventions, including hyperventilation, hyperosmolar therapy with 3% saline, and a paralytic
agent. A phenobarbital-induced coma with burst suppression
was started, which initially dropped the ICP to 10 mmHg, but
the ICP soon rebounded and increased to 40 mmHg. A left
decompressive hemicraniectomy was then performed, which
decreased the ICP to 15-20 mmHg. The patient’s initial laboratory workup was still pending, including blood, fungal cultures, CSF gram stain/cultures, and viral PCR. We sent out
the tick-borne disease panel, and doxycycline, azithromycin,
and atovaquone were empirically added to the aforementioned antibiotic therapy.
On day two post admission, the patient’s left scalp was
tense, and the right frontal EVD again demonstrated elevated
ICP. The elevated ICP was refractory to continued maximal
medical management, and the neurosurgery team performed
a right decompressive hemicraniectomy. Patient cultures and
the laboratory workup, as mentioned above, were all negative. Given patient’s presentation, with clinical signs and
travel history, amphotericin B and ﬂuconazole were added
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Figure 3: Naegleria trophozoites were rapidly identiﬁed by their large, round- to pear-shaped cells with a prominent, dark nucleus, and
scattered vacuoles. Images of Naegleria fowleri on Giemsa Wright-stained CSF slides (1000x, oil immersion). Black arrowheads point to
Naegleria trophozoites with a background of mostly RBC and some neutrophils.

(a)

(b)

Figure 4: MRI post 72 hours of admission. After uncomplicated wide bilateral craniectomies. (a) The sagittal view showing transtentorial
herniation with stretching and obliteration of the fourth ventricle. (b) Note on the axial view showing diﬀuse swelling with loss of gray
white junctions and absence of ventricular space.

to the treatment and more CSF sample was sent for parasite
smear to test for possible amoebic meningoencephalitis at
our institution.
On the third day post admission, parasite smear results
came back concerning for amoeba infection. We sent samples to the CDC, which conﬁrmed the diagnosis of Naegleria
fowleri (Figure 3). Vancomycin and acyclovir were discontinued, and we started the patient on amphotericin B, ﬂuconazole, and azithromycin. Despite the bilateral craniectomies
and other interventions, the patient’s ICP remained elevated,
and he started to demonstrate signs of brain death with MRI
revealing transtentorial herniation without uncal or subfalcine herniation (Figure 4). The physical exam oﬀ sedation
and nuclear medicine cerebral blood ﬂow study both conﬁrmed ﬁndings consistent with brain death, and we terminally extubated the patient.

3. Discussion
This case presents with a ﬁrst-ever reported case of PAM in
the state of New Jersey, and it highlights the importance of
keeping a clinical suspicion in mind regardless of geographic

location. The infection primarily aﬀects younger people who
are exposed to warm recreational freshwater in southern
states during the summer months [10]. Increased incidence
in young adults and children is likely more related to
water-related activities as they are more likely to dive, submerge the head in water, or engage in water sports like water
surﬁng, water rafting, and skiing that can force water up to
the cribriform plate from the nasal cavity. The patient presented with signs including fevers, chills, photophobia, confusion, with a tripod sign that indicates respiratory distress
and meningeal irritation, which required him to undergo
intubation immediately as his GCS was 7.
The diagnosis of PAM is challenging because of the similarities between the presenting symptoms of PAM and other
conditions, including bacterial meningitis. PAM is rapidly
progressive and has a devastating disease course that usually
occurs within 6-17 days after initial exposure. This can lead
to death if not promptly diagnosed [11]. Speciﬁc diagnostic
tools and general increased awareness of PAM are required
to initiate treatment sooner. In the few cases of PAM that
were successfully managed in the past, a correct and prompt
diagnosis was made [12, 13]. History of water exposure is
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critical in diagnosing PAM. The current case presented with
clinical signs and symptoms similar to previously documented cases [14, 15]. Symptoms of PAM are nonspeciﬁc
symptoms and include severe headache, high-grade fever,
confusion with altered level of consciousness, and neck stiﬀness. Death, in most cases, is due to increased intracranial
pressure and herniation, as seen in our patient (Figure 4).
N. fowleri induces pore-forming proteins that cause
lysis of mammalian cells on contact and secrete cytolytic
molecules, including acid hydrolases, phospholipases, neuraminidases, and phospholipolytic enzymes that degrade
mammalian tissue [1]. The organism also synthesizes regulatory surface proteins that confer protection to amoeba
against complement-mediated lysis and other cytotoxic substances, thus evading the host immune system [1]. Laboratory ﬁndings in patients with PAM are characterized by
increased leukocytes, which are predominantly polymorphonuclear cells. CSF may also be purulent with marked leukocytosis, increased protein, and reduced glucose level [14, 15]. In
most cases, neuroimaging tests in the early stages of the disease did not reveal any brain abnormalities [16]. However,
strong clinical suspicion of PAM with a previous history of
water exposure should guide the management of the patient’s
presentation in the absence of bacteria or fungi and CSF
specimens. Measures to avoid this fatal infection include
avoiding water-related activities in freshwater lakes, rivers,
or natural hot springs with high water temperatures.
Its low incidence limits eﬀective treatments for an N.
fowleri infection, and current treatment strategies are based
on case reports and in vitro animal studies. Amphotericin B
is a pharmacologic treatment with potential eﬃcacy when
started early. It acts by binding to ergosterol in the cell membrane with pore formation that leads to cellular lysis. In vitro
studies show a concentration of at least 0.1 μg/mL is needed
to suppress >90% of amoeba growth, and 0.8 mg/mL is
required to achieve 100% amoebicidal capability [17, 18].
Based on this, intravenous doses of amphotericin B of
0.25 mg to1.5 mg/kg/day are recommended in adults, while
doses ranging from 0.5 to 0.7 mg/kg/day is recommended
in pediatric patients [18]. CDC currently recommends intravenous or intrathecal (if ICP is increased) amphotericin B at
doses of 1.5 mg/kg/day in two divided doses for three days,
followed by 1 mg/kg/day once daily for an additional eleven
days with a total of 14 days of therapy [18]. Fluconazole, an
antifungal agent, may be eﬀective at a dose of 10 mg/kg/day
daily for 28 days. Fluconazole then synergistically works
with amphotericin B by inhibiting ergosterol synthesis. Also,
azithromycin, the macrolide antibiotic, has in vitro activity
against N. fowleri and is recommended to be used at
10 mg/kg/day once daily (maximum 500 mg daily dose) for
28 days [9]. Miltefosine, a drug eﬀective against leishmaniasis,
is another potential treatment for PAM recommended by the
CDC at doses of 50 mg orally two to three times daily (based
on body weight) with a maximum dose of 1.5 mg/kg/day for
a total of 28 days [18]. The exact mechanism is not precise;
however, it is believed to interact with phospholipids and steroid molecules in the cellular membrane.
PAM is almost always uniformly fatal. Early diagnosis
and aggressive treatment are crucial for recovery. In addition
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to pharmacologic management against amoeba, control of
high intracranial pressure, systemic inﬂammation, and possible induction of moderate hypothermia are a multidisciplinary approach in treating PAM [19]. Neuroprotective
management principles following any cerebral insult are
based on maintaining adequate cerebral perfusion, tempering oxygen consumption, and lowering ICP with mild to
moderate hypothermia (32-34°C). These steps reduce reactive oxygen species formation and proinﬂammatory cytokines halting neuronal apoptosis [20]. Of the 143 reported
PAM cases in the United States from 1962 to 2017, this is
the ﬁrst case reported in New Jersey. A high clinical suspicion is required to diagnose PAM for patients presenting
with nonspeciﬁc symptoms similar to bacterial meningitis.
History and physical exams are crucial in the diagnosis of
PAM as early as possible so that appropriate treatment
can be initiated, along with aggressive neurological critical
care management.
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